Jing-Ya Ding

Title: The Innovative Contributions of Jing-Ya Ding

Introduction

Jing-Ya Ding is a prominent inventor based in Taoyuan, Taiwan. She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 4 patents, her work focuses on developing antibodies that have therapeutic applications.

Latest Patents

One of her latest patents is titled "Anti-interferon gamma antibodies and uses thereof." This patent provides an anti-INF-γ antibody, along with a composition comprising the antibody and a pharmaceutical application for treating IFN-γ mediated syndrome. Another notable patent is "Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof." This patent discloses anti-GM-CSF antibodies that can bind to human GM-CSF and block its biological activities. It also includes pharmaceutical compositions comprising these antibodies and their therapeutic and diagnostic uses.

Career Highlights

Jing-Ya Ding is currently associated with Elixiron Immunotherapeutics (Hong Kong) Limited, where she continues to advance her research and development efforts in immunotherapy. Her work has the potential to significantly impact the treatment of various medical conditions.

Collaborations

Jing-Ya has collaborated with notable colleagues, including Cheng-Lun Ku and Han-Po Shih, who contribute to her innovative projects and research initiatives.

Conclusion

Jing-Ya Ding's contributions to the field of immunotherapy through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.